PlainPill

Escitalopram

Also known as Lexapro, Cipralex

The short answer. People are split on Escitalopram — 41% of 82 say it helped. It is most often used for mood: 80% of 44 reports say that improved. It is well studied — 219 meta-analyses on PubMed. The most common complaint is emotional blunting.

What users report
41%helped82 reports · medium confidence
34 helped22 mixed27 didn't help

From 135 mentions in total — the rest didn't say how it went and aren't counted.

Clinical research
AStrong research base
219
meta-analyses
659
RCTs
4,039
papers
Prescription medication. These are self-reported experiences, not dosing or treatment advice. Prescription drugs have real side effects and interactions — start, stop or change them only with a doctor. Share of positive reports is not a measure of safety.

What Escitalopram does, according to users

Of the people who reported each effect, the share who said it got better.

What the research says

Systematic reviews and meta-analyses from PubMed, with their published conclusions.

AStrong research base

3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 219 meta-analyses on PubMed ↗ · 659 randomized trials ↗

Lancet · 2018 · Meta-analysis / systematic review
Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis

Conclusion: All antidepressants were more efficacious than placebo in adults with major depressive disorder. Smaller differences between active drugs were found when placebo-controlled trials were included in the analysis, whereas there was more variability in efficacy and acceptability in head-to-head trials. These results should serve evidence-based practice and inform patients, physicians, guideline developers, and policy makers on the relative merits of the different antidepressants.

PubMed 29477251 ↗
Lancet · 2019 · Meta-analysis / systematic review
Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis

Conclusion: To our knowledge, this is the largest contemporary review of pharmacological agents for the treatment of generalised anxiety disorder by use of network analysis. There are several effective treatment choices for generalised anxiety disorder across classes of medication. The failure of initial pharmacological therapy might not be a reason to abandon a pharmacological treatment strategy.

PubMed 30712879 ↗
Mol Psychiatry · 2023 · Meta-analysis / systematic review
Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis

Conclusion: Compared to placebo, venlafaxine was associated with a lower incidence of dizziness, while desvenlafaxine, sertraline, and vortioxetine were associated with a higher incidence of nausea/vomiting. In conclusion, desvenlafaxine, paroxetine, venlafaxine, and vortioxetine had reasonable efficacy, acceptability, and tolerability in the treatment of adults with stable MDD.

PubMed 36253442 ↗
Registered clinical trials

725 human trials on ClinicalTrials.gov test Escitalopram — 474 completed, 34 recruiting now. See all on ClinicalTrials.gov ↗

What government agencies say

Official records from US, Canadian and EU regulators, each linked to its source.

FDA drug label

Boxed warning (the FDA's strongest label warning): “SUICIDAL THOUGHTS AND BEHAVIORS Antidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients in short-term studies. Closely monitor all antidepressant-treated patients for clinical worsening, and for emergence of suicidal thoughts and behaviors.…”

Full label on DailyMed (NIH) ↗

FDA recalls

2 recalls of products named for Escitalopram. Most recent:

  • 2016-09-28 · Class III: Labeling: Incorrect or Missing Lot and/or Expiration Date record ↗
  • 2014-01-29 · Class II: Labeling: Label Mixup: ESCITALOPRAM, Tablet, 5 mgmay have potentially been mislabeled as the following drug: SODIUM CHLORIDE, Tablet, 1 gm, NDC 00223176001,… record ↗

Class I = could cause serious harm; Class II = temporary or reversible harm; Class III = unlikely to cause harm. Recalls are of specific products and lots, not of the ingredient itself. All recalls (openFDA) ↗

Reports to the FDA about the drug (FAERS)

139,496 adverse-event reports mention Escitalopram. Most often reported:

  • Fatigue · 9,541
  • Nausea · 9,519
  • Drug ineffective · 8,998
  • Headache · 7,397
  • Diarrhoea · 7,046
  • Anxiety · 6,668

Reports often involve several drugs and serious illness; a report doesn't prove the drug caused the problem, and these counts can't tell you how often it happens. Source query (openFDA) ↗

US government research funding (NIH)

NIH has funded 14 research projects with Escitalopram in the title, $24,756,584 in total (2002–2025). NIH RePORTER ↗

Plain-language guides from the US government: MedlinePlus: Escitalopram ↗

Dosage people report

We don't list doses for prescription medications. Dosing should only come from a doctor or pharmacist.

Reported side effects

How often each side effect came up across all reports.

emotional blunting ×7withdrawal ×6fatigue ×4sexual dysfunction ×4brain fog ×3weight gain ×2insomnia ×1stomach issues ×1

What users say

First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.

“Escitalopram is what makes me feel normal, i react to it very quickly too, but it seems to induce hypomania on first days of intake. Brings me back confidence, ambition, motivation, energy, relieves anxiety, kicks depression.”
HelpedRead the discussion ↗
“I was on it for 7 months and improved my mood and lowered my anxiety. But it also made me apathetic/unmotivated, caused emotional blunting and sexual dysfunction.”
MixedRead the discussion ↗
“I've had a positive outcome, have no more anxiety, and these personality changes are welcomed.”
HelpedRead the discussion ↗
“I started lexapro last year and it changed my life for the better.”
HelpedRead the discussion ↗
Read more Escitalopram reviews →
Top discussions (5)

Escitalopram compared

Other options for mood

Sources

User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate